Research Status and Suggestion of Drug Clinical Trial Risk Management in China: Based on Co-word Analysis and Social Network Analysis Perspective / 中国医学伦理学
Chinese Medical Ethics
;
(6): 271-276, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-1005543
ABSTRACT
【Objective:
】 To deeply understand the current situation and hotspots of drug clinical trials risk management in China. 【Methods:
】 Co-word analysis and social network analysis were used to sort out the study results of risk management in drug clinical trials in China. 【Results:
】 The trend of risk research of drug clinical trials in China was generally on the rise. The research hotspots focused on four areas drug supervision and pharmacovigilance, risk management of drug clinical trial institutions, ethical review of drug clinical trials, and risk management of drug clinical trials. 【Conclusion:
】 In the future, China should gradually improve the risk management system and supervision system of drug clinical trials, explore to establish a risk-based quality management and ethical review system of drug clinical trials, and enhance the risk assessment and coping ability of institutions.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Medical Ethics
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS